Rosemont Pharmaceuticals
- Deirdre O.
Deirdre O.
Corporate Development | Head Of M&a at Rosemont Pharmaceuticals
Deirdre (Dee) O. is currently the Head of M&A at Rosemont Pharmaceuticals, the UK's leading liquid pharmaceuticals business. Prior to this role, Dee held leadership positions in corporate development at Oxford Biomedica, PwC, and Amdipharm Mercury Co. Dee holds a BSc (Hons) in Chemistry and Mathematics from University College Dublin, as well as a Certificate in Investments and Corporate Finance from The CISI, an MBA from The Open University Business School, and a PhD in Physical Organic Chemistry from University College Dublin.
Timeline
Corporate Development | Head Of M&a
January, 2024 - present
Related people
Tomer Stavitsky
VP, Corporate Development, Head of M&A at Ginkgo Bioworks
Paul Chu
Sr Director, Corporate Development, Head Of M&a Integration at Autodesk
Bobby Petska
Vice President, Corporate Development ◆ Head Of M&a ◆ Closed 5 Add-ons at Specialized Packaging Group
James Wu
Director Corporate Development & Head Of M&a at Umicore